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Evaluation of a Cognitive-Behavioral Mood Management Intervention for Depressed College
Smokers
Co-Chairperson: Duncan Campbell
Co-Chairperson: Kari Harris
College smoking correlates positively with depressive symptoms, and given the relation
between smoking and mood regulation, cigarette smoking is a major health concern among
depressed college smokers. This randomized clinical trial examined smoking reduction and
cessation among college smokers with elevated depressive symptoms participating in a groupbased multi-component intervention including mood management, behavioral counseling, and
motivational enhancement (CBT). Fifty-eight smokers (smoked 6 or more days in the past 30)
were randomized to six sessions of the experimental intervention (n = 29) or a nutrition-focused
attention-matched control group (CG; n = 29). Relative to CG participants, a significantly greater
proportion of CBT participants reduced smoking intensity by 50 percent or more at end of
treatment. In addition, confidence to reduce smoking increased significantly among CBT
participants and decreased among CG participants from baseline to end of treatment. Overall,
CBT participants maintained these changes at 3-month follow-up even though group differences
were no longer statistically significant. Study findings demonstrate the feasibility of this
intervention and support its utility for smoking reduction among depressed college students.
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INTRODUCTION
Cigarette Smoking among College Students
Smoking is relatively common among college students. Whereas 9% of college students
smoke daily, many more smoke occasionally (30-44%) (Johnston, O‟Malley, Bachman, &
Schulenberg, 2007), and these occasional smokers have similar difficulties with quitting as adults
(Okuyemi et al., 2002). In addition, although most people try their first cigarette before age 18
(Centers for Disease Control and Prevention, 1997a), cross sectional surveys show that 11-28%
of students begin smoking regularly while in college (Everett et al., 1999; Wechsler, Rigotti,
Gledhill-Hoyt, & Lee, 1998). Furthermore, a recent longitudinal study found that 12% of nonsmokers became occasional smokers and 14% of occasional smokers progressed to daily
smokers over the course of four collegiate years (Wetter et al., 2004). Taken together, research
on college students suggests that smoking patterns evolve during the college years. Moreover,
adult smoking patterns might become established in early adulthood, and therefore, college
students are important targets for interventions aimed at decreasing use and preventing future
smoking.
Despite the high prevalence of tobacco smoking among college students and the
feasibility of implementing programs into structured college or university settings (DeBernardo
et al., 1999), few interventions have been designed and tested for this population. Existing
cessation services often include „quit kits‟, self-help materials, and low-cost or free
pharmacological aids, yet few of these programs have been evaluated (Halperin & Rigotti, 2003;
Ramsay & Hoffmann, 2004). Moreover, most intervention research targeting college students
lacks methodological rigor, such as random sampling, control groups, random assignment to
groups, and biochemical validation of self-reported smoking (Murphy-Hoefer et al., 2005). A
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recent review of interventions designed to reduce tobacco smoking among college students found
seven published studies in the past 20 years. Of these seven studies, reviewers rated two
„satisfactory‟ and one „unsatisfactory‟ based on appropriateness of study design, follow-up and
completion rates, and data analysis. The remaining four studies were not rated due to small
sample sizes (≤ 25 participants) or lack of a comparison group (Murphy-Hoefer et al., 2005).
Despite methodological problems, the authors concluded that tobacco smoking interventions
may reduce tobacco use among college students (Murphy-Hoefer et al., 2005). Indeed, Ramsay
and Hoffmann (2004) found that a peer-led cessation and intervention program resulted in 88.2%
quit rates among college smokers. Chan and Witherspoon (1988) evaluated the efficacy of a brief
feedback counseling intervention and found it to be effective in increasing quit rates, reducing
number of cigarettes smoked per day, and preventing initiation of tobacco use. These studies,
though limited in number, suggest that smoking interventions may be successful in altering use
among college students. Clearly, additional intervention research is needed for this population.
Depression and Cigarette Smoking
Research with adolescents and adults documents the association between depression and
cigarette smoking. Among adolescents, depressive symptoms and depression diagnoses
demonstrate cross-sectional associations with nicotine smoking and dependence (Breslau,
Kilbey, & Andreski, 1991; Patton et al., 1996). Furthermore, research identifies depression as an
important factor in the initiation and progression of adolescent smoking behavior (Brown,
Lewinsohn, Seeley, & Wagner, 1996; Kandel & Davies, 1986; Patton et al., 1998; Windle &
Windle, 2001), and other research suggests this relationship is bidirectional such that smoking
may increase the risk for subsequent depressed mood (Steuber & Danner, 2006; Wu & Anthony,
1999). Large population-based studies among adults observe higher rates of depression
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diagnoses and symptoms in smokers than non-smokers (Anda et al., 1990; Glassman et al., 1990;
Murphy et al., 2003). Other studies document a relationship between major depression (MDD)
and nicotine dependence (Breslau et al., 1991; Breslau, Kilbey, & Andreski, 1993; Carton,
Jouvent, & Widlocher, 1994), and level of nicotine consumption (Kendler et al., 1993).
Furthermore, 61% of participants in a smoking cessation trial reported past MDD (Glassman et
al., 1988), and other trials reveal that 34% to 48% of enrolled smokers present with clinically
significant depressive symptomatology (Kinnunen, Doherty, Militello, & Garvey, 1996; Lerman
et al., 1996; Lerman et al., 1998).
Numerous recent studies demonstrate that the relationship between depression and
smoking extends to young adults, including college students. For example, a national study of
young adult smokers found depressive symptoms to be a unique predictor of lifetime and current
nicotine dependence (Hu, Davies, & Kandel, 2006). In other studies of young adults, nicotine
dependence was associated with higher rates of MDD (Breslau et al., 1991), and a history of
MDD increased the risk for progression to daily smoking (Breslau, Peterson, Schultz, Chilcoat,
& Andreski, 1998) and nicotine dependence (Breslau, Fenn, & Peterson, 1993). Research among
college students reveals a relationship between a history of depression and smoking (Lenz, 2004;
McChargue, Spring, Cook, & Neumann, 2004). Recent research has also shown that current
cigarette and tobacco users report a significantly higher number of depressive symptoms
(measured by the CES-D) than non-cigarette and non-tobacco users (Lee Ridner, Staten, &
Danner, 2005; Vickers et al., 2003). Furthermore, a positive correlation exists between
depressive symptoms and smoking level among college smokers (Lee Ridner et al., 2005;
Schleicher, Harris, Catley, & Nazir, In Press). To this writer‟s knowledge, only one study failed
to observe a relationship between depressive symptoms and nicotine dependence (Psujek, Martz,
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Curtin, Michael, & Aeschleman, 2004). Accordingly, development of novel and efficacious
smoking interventions for the subpopulation of depressed college student smokers is warranted.
Depression and Smoking Cessation
There is some evidence to suggest that depression impedes smoking cessation efforts.
With regard to the relationship between past MDD and smoking cessation likelihood, findings
are equivocal. Whereas some studies observed that past depression decreases likelihood of
smoking cessation (Anda et al., 1990; Glassman et al., 1988; Murphy et al., 2003), others have
not (Breslau et al., 1998; Ginsberg et al., 1997; John, Meyer, Rumpf, & Hapke, 2004a; Niaura et
al., 1999). Results of a recent meta-analysis suggest that history of MDD is not an independent
risk factor for cessation failure (Hitsman, Borrelli, McChargue, Spring, & Niaura, 2003);
however, recurrent MDD might have a stronger relationship with quitting than a single past
episode (Covey, Hughes, Glassman, Blazer, & George, 1994; Hitsman et al., 2003).
Although a history of MDD is not consistently associated with cessation failure, currently
depressed smokers (categorized based on symptoms of depression or diagnosis of depression) are
less likely to stop smoking (Anda et al., 1990) and have higher relapse rates than nondepressed
smokers (Hayford et al., 1999; Kinnunen et al., 1996; Niaura et al., 2001). Taken together,
research suggests that current depressive symptoms may be a more important predictor of
treatment outcome than history of MDD. This is especially true given that even low levels of
baseline depressive symptoms predict poorer smoking abstinence rates (Niaura et al., 2001).
Self-medication Model of Smoking and Depression
A self-medication model has been used to account for the association between smoking
and depression. According to this model, smokers “self-medicate” with nicotine to alter mood
states by decreasing negative affect and increasing arousal (Carmody, 1989; Hall, Munoz, Reus,
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& Sees, 1993; Hughes, 1988; Lerman et al., 1996; Pomerleau & Pomerleau, 1984). Research
demonstrates that negative affect regulation expectancies, or beliefs about whether or not
smoking will alleviate negative affect, might contribute to increased smoking. For example,
among adolescents, affect regulation expectancy was related to experimental, regular, and
established smoking (Mayhew, Flay, & Mott, 2000). In a sample of adults, depressed smokers
reported smoking more in the presence of negative affect and had fewer coping resources than
non-depressed smokers (Kinnunen et al., 1996). In other studies among adult smokers, negative
affect regulation expectancies mediated the relationship between depressive symptoms and
negative affect, on the one hand, and nicotine dependence on the other (Copeland, Brandon, &
Quinn, 1995; Lerman et al., 1996). It is possible that depressed smokers have fewer coping
resources than non-depressed smokers, and thus have a greater expectation that smoking will
regulate mood.
College students also report smoking to manage depression and stress (Patterson,
Lerman, Kaufmann, Neuner, & Audrain-McGovern, 2004). For example, college student tobacco
users with elevated depressive symptoms appear to be more likely to use tobacco for mood
improvement than tobacco users with low depressive symptoms (Vickers et al., 2003). While one
study found that negative affect regulation expectancies did not mediate the relationship between
a history of depression and smoking status among college students (McChargue et al., 2004), a
different study found that these expectancies did mediate the relationship between depressive
symptoms and college student smoking status (Schleicher et al., In Press). Consequently, it
appears that current depressive symptoms may be a more important predictor of negative affect
regulation expectancies than history of depression.
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Mood Management Interventions for Depressed Smokers
Researchers have attempted to improve smoking cessation outcomes for depressed
smokers with treatments targeting negative affect. Cognitive-behavioral mood management
interventions (CBT) have become a recent focus of investigation as a smoking treatment adjunct
for adult smokers with depression. Two studies by Hall and colleagues (1994; 1998)
demonstrated that CBT was more effective than a behavioral smoking cessation treatment for
smokers with a past history of MDD. However, when therapist contact time was controlled, there
was no effect of CBT on smokers with a history of MDD (Hall et al., 1996). On the other hand,
another study demonstrated that a 12-week CBT intervention was superior to a 12-week
behavioral counseling intervention for adult smokers with histories of MDD and alcohol
dependence (Patten, Martin, Myers, Calfas, & Williams, 1998). Results of two recent studies
suggest that CBT may be superior to standard behavioral counseling for individuals with a
history of multiple depressive episodes versus a single past episode of depression (Brown et al.,
2001; Haas, Munoz, Humfleet, Reus, & Hall, 2004).
The findings in support of CBT for individuals with multiple past episodes of MDD
parallels the research regarding historical depression and smoking abstinence and may explain
the inconsistent results of the efficacy of CBT for historical depression. For example, smokers
with recurrent MDD may have higher levels of mood disturbance than those with a single
episode and thus may benefit from the addition of CBT to standard behavioral counseling (Haas
et al., 2004). If this is the case, then CBT is likely to be valuable for smokers with clinically
elevated depressive symptoms. Indeed, although most studies examining CBT for smoking
exclude participants with current depression, additional research suggests that this type of
intervention may be beneficial for smokers with current depressive symptoms. One study found
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that smokers with high levels of baseline negative affect benefited more from CBT than smokers
with low levels of negative affect (Brandon, Copeland, & Saper, 1995). In another study,
participants high in baseline negative affect responded best to supportive counseling, while those
low in negative affect responded best to skills training (Zelman, Brandon, Jorenby, & Baker,
1992). Furthermore, in a recent study of adult smokers with a past history of alcohol dependence,
post-treatment abstinence rates were higher for smokers with high baseline depressive symptoms
who participated in CBT than for those in behavioral counseling (Patten, Drews, Myers, Martin,
& Wolter, 2002). On the other hand, smokers with low baseline depressive symptoms responded
better to behavioral counseling than to CBT. These results were significant after adjusting for
history of MDD. The authors concluded that current depressive symptoms provide additional
information in predicting short-term outcome beyond a diagnosis of major depression (Patten et
al., 2002). Interestingly, three other studies did not find independent effects for baseline
depressive symptoms or negative mood on abstinence rates following CBT (Brown et al., 2001;
Brown et al., 2007; Haas et al., 2004). The conflicting findings among studies evaluating the
effectiveness of CBT interventions for smokers experiencing depressive symptoms or negative
affect may be related to symptom severity. For example, mood management interventions may
be more effective for those with clinically elevated depressive symptoms than low or moderate
levels of symptomatology (Brown et al., 2007). Given the strong positive correlation between
high depressive symptoms and smoking, it is imperative for research studies to continue to
develop and test interventions for this population.
Summary
Traditional CBT depression interventions treat current low mood and stress, yet few
studies have targeted smokers with current clinical elevations in depression. As noted above,
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depression and smoking are related, and current depressive symptomatology has the potential to
impact smoking cessation efforts. Given the possible benefit of CBT for smoking, researchers
should continue to develop and test interventions for depressed smokers. The college years
represent a unique opportunity for psychotherapeutic interventions with potential to alter the
course of lifelong smoking patterns. Moreover, college is a period of transition in which many
experience negative mood (Eisenberg, Gollust, Golberstein, & Hefner, 2007). The selfmedication model suggests the likelihood that many college students will initiate, maintain, or
increase smoking to cope with stress and negative affect. To date, however, no research has
evaluated the effectiveness of mood management interventions for college student smokers
experiencing high levels of depressive symptoms.
To address this need, this study implemented a group-based CBT intervention targeting
smoking reduction and cessation among college student smokers (smoking ≥ 6 days in the past
30) with clinically elevated depressive symptomatology. For safety concerns, we excluded
participants experiencing a current major depressive episode (MDE) (n = 4). The multicomponent CBT intervention combined mood management, behavioral counseling and
motivational enhancement. We targeted occasional and daily smokers with varying interest in
quitting because we wanted to derive a sample representative of the smoking college student
population and because recent research suggests that the prevalence of occasional smoking is
increasing (Tong, Ong, Vittinghoff, & Perez-Stable, 2006). Our intervention included a
motivational enhancement component because we did not recruit students seeking treatment for
smoking and, therefore, anticipated variability in their motivation to change their smoking
behavior. Finally, in addition to smoking cessation, we targeted smoking reduction because of
recent positive findings regarding reduction interventions for smokers not motivated to quit
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(Hughes & Carpenter, 2005) and the apparent finding that these reductions might facilitate future
cessation efforts (Carpenter, Hughes, Solomon, & Callas, 2004; Hughes & Carpenter, 2006).
HYPOTHESES
Primary Hypotheses
Hypothesis 1
Relative to participants in a nutrition-focused attention-matched control group (CG),
participants receiving a multi-component experimental intervention (CBT) for smoking will have
significantly higher 30-day abstinence (defined as no cigarettes in the past 30 days) at end of
treatment (session 6; 8 weeks from baseline).
Hypothesis 2
Relative to CG participants, a significantly greater proportion of participants receiving
CBT will achieve 50% or greater reduction in number of cigarettes smoked per month at end of
treatment (session 6; 8 weeks from baseline).
Secondary Hypotheses
Hypothesis 3
Relative to CG participants, participants receiving CBT will have significantly higher 30day abstinence (defined as no cigarettes in the past 30 days) at 3-month follow-up (12 weeks
from baseline).
Hypothesis 4
Relative to CG participants, a significantly greater proportion of participants receiving
CBT will achieve 50% or greater reduction in the number of cigarettes smoked per month at 3month follow-up (12 weeks from baseline).
Exploratory Hypotheses
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Hypothesis 5
CBT for college student smokers with elevated depressive symptoms will be feasible, as
evidenced by our ability to recruit and retain participants, treatment attendance, and participants‟
reports of treatment satisfaction.
Hypothesis 6
Comparing baseline to end of treatment and 3-month smoking levels, participants
receiving CBT will have a significantly greater reduction in overall number of cigarettes smoked
per month than participants in CG.
Hypothesis 7
Relative to CG participants, CBT participants will report significantly higher motivation
and confidence to quit and reduce smoking at end of treatment and 3-month follow-up.
Hypothesis 8
Relative to CG participants, CBT participants will report significantly less severe
depressive symptoms, negative affect, and negative affect regulation expectancies, and will
report significantly higher positive affect and increased use of cognitive reappraisal strategies at
end of treatment and 3-month follow-up.
Hypothesis 9
The relationship between baseline depressive symptoms and treatment attendance will be
explored.
METHODS
Participants and Procedure
As presented in the sampling diagram (Figure 1), 1,380 participants aged 18 years or
older completed screening measures over the course of three academic semesters (2007-2008).
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Participants completed measures during “Testing Day,” an event sanctioned by The University
of Montana Psychology Department in which students enrolled in introductory psychology
courses earn required research participation credit. Study personnel contacted participants via
telephone who agreed to follow-up contact and met the following screening criteria: smoking ≥ 6
days in the past 30, clinically significant depressive symptomatology (Center for
Epidemiological Studies-Depression Scale (CES-D) sum ≥ 16 (Radloff, 1977)), and a degree of
motivation to quit smoking (Contemplation Ladder rating ≥ 3, indicating some awareness of
problems associated with smoking (Abrams et al., 2003; Biener & Abrams, 1991)). During a
follow-up phone call, study personnel described the study, assessed exclusion criteria, and
enrolled interested and consenting participants. Participants were excluded if they reported recent
(past 30 days) participation in a structured smoking cessation program (n = 0), and for safety
reasons if they reported current suicidal intent or plans (n = 0) or current MDE (n = 4, indexed
using a diagnostic algorithm from the Patient Health Questionnare-9 (Kroenke, Spitzer, &
Williams, 2001)). Table 1 summarizes inclusion and exclusion criteria.
As shown in Figure 1, 58 undergraduate smokers with clinically elevated depressive
symptomatology were randomized to participate in the CBT and CG groups. The 58 eligible
participants were individually randomized to groups using a random number table and blocked
random assignment. We blocked according to CDC-defined (Center for Disease Control and
Prevention, 1994) smoking level (occasional smoking ≤ 19 days in the past 30 vs. frequent
smoking ≥ 20 days in the past 30) and motivation to quit (Contemplation Ladder score ≤ 5 vs. ≥
6) so that groups were matched on these characteristics at baseline. Major assessment intervals
occurred at screening, baseline (session 1: week 0), end of treatment (session 6: week 8), and 3month follow-up (12 weeks from baseline). The first five group sessions occurred weekly, and
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the last group session took place 30 days after session 5 in order to assess 30-day smoking
outcomes at end of treatment. The following incentives were provided: 1) partial course credit;
2) non-monetary incentives (e.g., campus coupons and pizza at group sessions); 3) $50 for
completing study measures. In addition, for each attended group session, participants entered
their names in a drawing to win an iPod at the final group session. The Institutional Review
Board at The University of Montana (UM) approved all study procedures; participants provided
informed consent at screening and baseline. Table 2 summarizes the study overview and
disbursement of incentives.
Interventions
Treatment Condition
The treatment condition was an adaptation of a 12-week group-based combined
behavioral counseling plus cognitive-behavioral mood management intervention (CBT). The
original intervention significantly enhanced smoking treatment outcomes among abstinent
alcoholics with a history of major depression in a previous study (Patten et al., 1998). This
intervention was also found to be more effective than standard behavioral counseling for
smokers experiencing high levels of current depressive symptomatology (Patten et al., 2002). We
modified the 12-week intervention by reducing the number of sessions to 6 and keeping the
session length at two hours for a couple of reasons. First, college students appear to value timelimited interventions (Black & Babrow, 1991), and Dr. David Brown, a psychologist and group
psychotherapist at the UM student counseling center, advised against conducting more than 6
sessions due to participant attrition. Second, given that our primary outcome was 30-day
smoking rate at end of treatment, we required 30 days between the final two sessions. This
requirement made 6 sessions a more feasible option. We maintained the group-based approach
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for the purpose of replication and time and cost considerations. Although the sessions were
group-based, group discussion and problem solving allowed for some personalized instruction.
In addition to the manual cited above, material from a clinical handbook on tobacco dependence
treatment outlining an 8-week intensive mood management intervention was incorporated
(Abrams et al., 2003). Participants were taught that smoking is a learned behavior, a physical
addiction, and that smoking is related to mood. The CBT component outlined associations
among triggers, thoughts, feelings, and behavior. Participants recorded their thoughts, and
identified and challenged thought distortions related to negative mood and/or smoking. We also
taught additional ways of managing mood, such as increasing pleasant smoke-free activities and
relaxation. The behavioral counseling component included skills training such as self-monitoring
of smoking and triggers, self-management strategies, making a quit or change plan, and relapse
prevention. Finally, the smoking intervention included motivational approaches (Miller &
Rollnick, 2002) such as expressing understanding, rolling with resistance, developing
discrepancy (e.g., values clarification and pros and cons), and increasing self-efficacy. For
example, participants ranked their motivation and confidence to quit on a scale from 1 (no
motivation/confidence) to 10 (high motivation/confidence), and group leaders facilitated a
dialogue about their locations on the scale. The group also created a pros and cons list of
smoking and of quitting and/or reducing smoking. As outlined in Table 3, participants were
given the opportunity to make a quit or change plan at session 4 and were given instructions on
obtaining low-cost pharmacotherapy to support cessation efforts. Treatment groups were
conducted by two graduate students in clinical psychology, including this writer, and they
received weekly supervision from David Brown, Ph.D., a clinical psychologist at The University

14
of Montana‟s Counseling and Psychological Services (CAPS). In addition, Drs. Harris and
Campbell provided consultation as needed.
Control Condition
The active control condition was a 6-session group designed to increase the consumption
of fruit and vegetables to equate clinical contact time across experimental and control conditions.
Neither smoking nor smoking cessation was discussed in the nutrition groups. Control groups
were conducted by two graduate students in psychology or public health, and Drs. Harris and
Campbell provided weekly supervision.
Table 3 outlines the topics covered in the treatment and control conditions. Treatment
groups took place at CAPS and control groups took place either at CAPS or the psychology
building on campus. For the first two cohorts, all group leaders and supervisors attended a twohour peer-led motivational interviewing training. For the third cohort, all group leaders attended
a two-day motivational interviewing workshop. Group leaders met at least once before groups
began to review curricula. Weekly supervision included a review of plans for upcoming sessions.
Measures
Screening Measures
Demographics. At screening, socio-demographic information (gender, age, and year in
school) was assessed via self-report.
Depressive Symptoms. The 20-item CES-D (Radloff, 1977) assessed depressive
symptoms. Scores range from 0 to 60, with higher scores reflecting a greater number of
depressive symptoms. The CES-D correlates highly with other self-report measures of
depression and evidences good internal consistency (α = .85-.90) and test-retest reliability (r =
.57 for 2-8 weeks) (Radloff, 1977). We used the standard cutoff score (Sum ≥ 16) to define

15
clinically significant depression. For missing items on the CES-D, we used item-mean
imputation for participants with four or fewer items missing (n = 54 one item missing, n = 6 two
items missing) (Bono, Ried, Kimberlin, & Vogel, 2007). The CES-D evidenced good internal
consistency in the present sample (α = .89).
Smoking Status. The Center for Disease Control and Prevention open-ended question,
“During the past 30 days, on how many days did you smoke cigarettes?” assessed smoking status
(1997b). Those who reported smoking on 6 or more days were considered eligible.
Motivation to Quit. The Contemplation Ladder assessed motivation to quit smoking
(Abrams et al., 2003; Biener & Abrams, 1991). This measure consists of an 11-point Likert scale
measuring readiness to quit smoking, with a higher score representing greater motivation to
change smoking behavior (e.g., “I have decided to quit smoking”) and a lower score representing
less motivation to change (e.g., “I do not have a problem with smoking, and I do not intend to cut
down or quit now”). Participants select the response that best describes their thoughts about their
current smoking. The validity of the Contemplation Ladder has been demonstrated by comparing
it to reported intention to quit and number of previous quit attempts, and by its ability to predict
participation in treatment programs (Biener & Abrams, 1991). Participants scoring three or
higher on this measure were considered eligible.
Major Depressive Disorder. The 9-item Patient Health Questionnaire (PHQ-9) assessed
for current MDE (Kroenke et al., 2001). Items assess the frequency with which the respondent
experiences the 9 DSM-IV criteria for MDE; items are scored from 0 (“not at all”) to 3 (“nearly
every day”). Total scores range from 0-27. We used a scoring algorithm such that individuals
were excluded on the basis of MDE if: (1) they endorsed experiencing 5 of the 9 symptoms for at
least “more than half the days” in the past 2 weeks (i.e., score at least “2” on 5/9 questions), (2)
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one of the symptoms was depressed mood or anhedonia, and (3) they endorsed an additional item
that assesses whether any of the measure‟s nine symptoms causes clinically significant
impairment (Kroenke et al., 2001). Research suggests that a PHQ-9 score of 10 or more is a
reliable and valid indicator of MDE (Adewuya, Ola, & Afolabi, 2006; Kroenke et al., 2001). The
PHQ-9 has demonstrated good construct, concurrent, and criterion validity, and has been shown
to have good internal consistency and test-retest reliability (Adewuya et al., 2006; Kroenke et al.,
2001). In addition, a recent study demonstrated that use of the PHQ-9 as a telephone screening
assessment is concordant with self-administration and preserves the internal consistency of the
items (Pinto-Meza, Serrano-Blanco, Penarrubia, Blanco, & Haro, 2005). The scale evidenced
acceptable internal consistency in this sample (α = .71).
Baseline, End of Treatment, and Follow-up Measures
Demographics. At baseline only, ethnicity and previous and current counseling
experience were assessed via self-report (e.g. “Have you ever received psychological counseling
in the past?” and “Are you currently receiving psychological counseling?”).
Smoking Status. Baseline and outcome smoking status were assessed by two forms of
self-report. First, participants answered a single Center for Disease Control and Prevention
(1997b) question (“During the past 30 days, on how many days did you smoke cigarettes?”).
Data from this question were used for descriptive purposes only. Second, timeline follow-back
(TLFB) procedures (Harris et al., In Press; Sobell & Sobell, 1996) assessed number of cigarettes
smoked in the past 30 days. Trained independent evaluators instructed participants to use a
calendar and memory aids (e.g., key dates like birthdays, exams, holidays) to provide
retrospective estimates of the number of cigarettes smoked each day. To reduce intentional
inaccuracy of these data we obtained saliva samples at end of treatment, informing participants
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that samples would be tested for nicotine (Murray & Perry, 1987). All smoking outcomes were
derived from TLFB data. For missing TLFB data, we inserted data based on smoking patterns
from weekday and weekend use reported in the current month. Five participants had one item
missing and two participants had two items missing.
Motivation and Confidence. Four separate questions were modified from Miller and
Rollnick (1991) to assess motivation and confidence to quit and reduce smoking at baseline and
end of treatment. Participants indicated their levels of motivation and confidence to quit and
reduce smoking on scales ranging from 0 (not at all motivated/confident) to 10 (Very
motivated/confident).
Depressive Symptoms. The 21-item Beck Depression Inventory-II (BDI-II, Beck, Steer,
& Brown, 1996) assessed depressive symptoms. Scores range from 0 to 63, with higher scores
reflecting more depressive symptomatology. The BDI-II demonstrates good internal consistency
reliability (α = .93) and construct validity (Beck et al., 1996). At baseline the BDI-II evidenced
good internal consistency in this sample (α = .90). For missing BDI-II data (n = 4 one item
missing) we replaced missing items with the mean values of the valid data by participant (Bono
et al., 2007). Group leaders monitored suicidal ideation by assessing BDI-II item #9 (Suicidal
Thoughts or Wishes). For any response other than „0‟ group leaders conducted a targeted suicide
assessment. Participants reporting suicidal ideation or other concerning psychiatric symptoms
were referred for treatment at CAPS.
Negative and Positive Affect. The 20-item Positive Affect Negative Affect Schedule
(PANAS) (Watson, Clark, & Tellegen, 1988) assessed positive and negative affect. The PANAS
consists of two 10-item scales (Positive Affect, PA and Negative Affect, NA). The two scales
have high internal consistency reliabilities (α = .84 to .90) and low intercorrelations (rs = -.12 to
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-.23). At baseline, the NA scale evidenced acceptable internal consistency in this sample (α =
.73), and the PA scale evidenced good internal consistency (α = .88).
Smoking Expectancies. The 4-item Negative Affect Reduction (NAR) subscale of the
Brief Smoking Consequences Questionnaire (SCQ) for college students (Schleicher, Harris,
Catley, Harrar, & Golbeck, 2008) measured participants‟ expectancies that smoking would assist
with negative affect regulation. Participants indicated the likelihood of smoking consequences on
a Likert-type scale ranging from 0-10 (0=Not at all likely, 10=Extremely likely); higher scores
reflected greater outcome expectancies (e.g., “Smoking calms me down when I feel nervous,” “If
I am feeling irritable, a smoke will help me relax.”). The NAR subscale evidenced good internal
consistency reliability in another college sample (α = .92) (Schleicher et al., 2008) and in this
study at baseline (α = .85).
Cognitive Reappraisal. The 6-item Reappraisal subscale of the Emotion Regulation
Questionnaire (ERQ) assessed cognitive reappraisal (Gross & John, 2003). The Reappraisal
subscale measures the extent to which participants use cognitive strategies to alter their emotions
(e.g., “When I want to feel less negative emotion (such as sadness or anger), I change what I‟m
thinking about”). Items are rated on a scale from 1 (strongly disagree) to 7 (strongly agree), with
higher scores representing higher use of reappraisal as an emotion regulation strategy. In a
college sample, the Reappraisal subscale demonstrated good internal consistency reliability
(mean α = .79 across 4 samples) and convergent and discriminant validity (Gross & John, 2003).
At baseline, the Reappraisal subscale evidenced good internal consistency in this sample (α =
.85).
Pharmacotherapy Use. Pharmacotherapy use (i.e., any prescription drug) was assessed via
self-report and included drug names, dosage, and dates of use. For descriptive purposes, drugs
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were coded as present (1) or absent (2) for four drug categories of interest (anti-depressant,
stimulant, mood stabilizer/anti-psychotic, and benzodiazepine). In addition, presence (1) or
absence (2) of any psychotropic medication was coded.
Additional Measures
Treatment Attendance. Participants signed in at each weekly session (baseline included)
and were coded as 0 (absent) or 1 (present/made up session). Attendance scores were summed
with scores ranging from 0 (no sessions attended) to 6 (all sessions attended). This sum provided
an index of treatment adherence.
Treatment Satisfaction. Slightly modified versions of the 8-item Client Satisfaction
Questionnaire (CSQ-8) (Attkisson & Zwick, 1982) assessed participants‟ satisfaction with both
intervention conditions at end of treatment. Two forms were created specific to each
intervention; questions addressed the helpfulness of the intervention (e.g., “How would you rate
the helpfulness of this group for quitting smoking (CBT)/increasing fruit and vegetable
consumption (CG)?”) and the likelihood of recommending the intervention to a friend (e.g., “If a
friend were thinking about quitting or reducing his/her smoking (CBT)/increasing his/her fruit
and vegetable consumption (CG), would you recommend our program to him/her?”). Items are
scored on a 4-point Likert scale with “1” indicating the lowest degree of satisfaction and “4” the
highest. Scores range from 8-32, with higher scores indicating higher satisfaction.
Therapist Adherence. To assess therapist adherence to the treatment manuals, group case
notes for all cohorts and group sessions were read by two blind raters. Global topics were
provided to the raters (e.g, CBT, behavioral counseling for smoking cessation, motivational
enhancement, and fruit and vegetable education), and each rater indicated which topics were
covered per session. Inter-rater agreement was high for CBT (κ = .88), behavioral counseling (κ
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= .94), and fruit and vegetable education (κ = .94), and moderate for motivational enhancement
(κ = .53). We chose to examine topics across sessions rather than per session for each cohort
because dynamic improvements were made to the interventions (e.g., which topics were covered
per session) for each cohort. The percent of sessions (averaged across raters) each topic was
covered per cohort by intervention group is reported in table 4.
Power Analysis
An a priori power analysis indicated sufficient power (0.80) for n = 50 participants to
detect a difference in abstinence rates at end of treatment between treatment and control groups.
The abstinence rates for the control group (4% & 6%) were based on estimates of spontaneous
and minimal intervention quit rates in the general population (Centers for Disease Control and
Prevention, 1993; Curry, McBride, Grothaus, Louie, & Wagner, 1995; Glynn, Boyd, & Gruman,
1990). Abstinence rates for the treatment group (38% to 69%) were based on previous studies of
CBT for smoking cessation among adult smokers with and without a history of depression
(Brown et al., 2001; Hall et al., 1996; Patten et al., 1998).
Data Analyses
We conducted analyses using two-tailed tests with p < .05 level of significance.
Descriptive statistics summarized sample characteristics at screening and baseline. Group
differences were assessed using independent t-tests for continuous variables and Pearson‟s Chisquare test for categorical variables (Fischer‟s Exact when noted). We identified potential
outliers for the TLFB (n = 2), NA subscale of the PANAS (n = 1), and BDI-II (n = 2) at baseline.
Statistical significance of results did not change when outliers were excluded, so we included
them in all analyses.

21
Primary and Secondary Hypotheses
To test 30-day point prevalence abstinence and 50% smoking reduction at end of
treatment and 3-month follow-up (Hypotheses 1-4), we employed intent-to-treat analysis with all
58 randomized participants using the Chi-square statistic. For abstinence outcomes, participants
were coded as smokers if they (1) reported smoking within the past 30 days; or (2) did not
complete the end of treatment/3-month follow-up measures. For reduction outcomes, participants
were coded as not reducing by 50% or more if they (1) did not reduce smoking by 50%; or (2)
did not complete the end of treatment/3-month follow-up measures. In essence, the intent-to-treat
analysis strategy identified participants with missing data as smokers. There were no significant
differences between the intervention groups for any demographic or baseline variables. Thus, we
did not statistically control for these variables in any of the models.
Exploratory Hypotheses
Feasibility estimates (Hypothesis 5) were determined by the ability to recruit and retain
participants, treatment attendance, and treatment satisfaction, and were assessed by the following
methods: Descriptive statistics summarized data related to participant recruitment and retention
(Figure 1), including the total number of potential participants screened, excluded, and the
number of participants that discontinued participation. In addition, descriptive statistics
summarized treatment attendance and treatment satisfaction.
For the remaining exploratory analyses, participants who completed at least 1 treatment
session and for whom we had end of treatment/3-month follow-up data were included (n = 46 for
end of treatment and n = 35 for 3-month follow-up). We excluded from end of treatment
analyses 12 participants who did not complete any treatment sessions (n = 3), did not provide
end of treatment data (n = 4), or did not complete sessions and did not provide end of treatment
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data (n = 5). We excluded from 3-month follow-up analyses 23 participants who did not
complete any treatment sessions (n = 3), did not provide 3-month follow-up data (n = 15), or did
not complete sessions and did not provide 3-month follow-up data (n = 5). Repeated measures
analysis of variance (ANOVA) compared differences in the number of cigarettes smoked per
month, motivation, confidence, and affective and cognitive measures (Hypotheses 6-8) between
CBT and CG participants from baseline to end of treatment and 3-month follow-up. A main
effect for time and a treatment by time interaction were assessed. Lastly, to examine the
relationship between baseline depressive symptoms and treatment attendance, linear regression
analyses were employed across treatment condition (n = 53) with treatment attendance (sum of
sessions attended, range = 0-6) as the criterion and baseline depression (BDI-II) as a main effect
predictor.
RESULTS
Screened participants (n = 1,380) were mostly female (61.6%), Freshmen (71.2%), and
had a mean age of 19.68 years (SD = 3.47) (Table 5). The mean number of days smoked in the
past 30 days was 3.88 (SD = 8.90, Mdn = 0.00), and the mean CES-D score was 13.81 (SD =
9.21). Scores on the Contemplation Ladder (M = 5.57, SD = 3.47) suggested that screened
participants were thinking about quitting smoking at baseline, but had not made any definite
plans to do so. Participants who consented to follow-up contact had significantly higher mean
30-day smoking (t(616) = 6.32, p < .001) and depressive symptoms (CES-D) (t(410) = 3.28, p =
.001) than participants who preferred not to be contacted. As expected, relative to ineligible
participants (n = 1322), eligible participants (n = 58) had significantly higher 30-day smoking
(t(62) = -19.81, p < .001), depression (t(1362) = -10.70, p < .001), and Contemplation Ladder
scores (t(149) = -3.71, p < .001). In addition, eligible participants were significantly older than
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non-eligible participants (t(60) = -2.34, p = .023) (Table 5). Among participants contacted via
telephone for follow-up screening, those who agreed to participate (n = 58) were similar to those
who refused or could not be reached (n = 24) (all ps > .05) on age, smoking rate (number of days
smoked in past 30), depressive symptoms (CES-D), and motivation to quit (Contemplation
Ladder).
Table 6 presents demographic characteristics and baseline measure scores of the study
sample that completed baseline questionnaires (n = 53) by intervention group (CBT and CG). No
significant differences (all ps > .05) were observed between groups. At baseline, participants (n =
53) were mostly Freshmen (67.9%) and had a mean age of 21.19 years (SD = 4.60) (Table 6).
Over half (60.4%) reported past psychotherapy experience and almost 20% reported taking a
psychotropic medication. Specifically, 11.3% reported taking antidepressants, 5.7% stimulants,
3.8% mood stabilizers or anti-psychotics, and 3.8% benzodiazepines. The mean number of days
smoked in the past 30 days was 24.77 (SD = 7.11) and 39.6% used other tobacco in addition to
cigarettes. The mean BDI-II score was 13.71 (SD = 8.82), indicating mild depressive
symptomatology. No significant differences existed between participants that completed baseline
(n = 53) and those that did not complete baseline (n = 5) on screening variables such as
demographic characteristics (age, gender, year in school), 30-day smoking, depression (CES-D
and PHQ-9), and motivation (Contemplation Ladder) (all ps > .05).
For the secondary and exploratory outcome analyses, only participants who completed at
least one group session and end of treatment/3-month follow-up data were included (n = 46 at
end of treatment and n = 35 at 3-month follow-up). No significant differences existed between
these participants (n = 46 and n = 35) and those who did not complete group sessions and end of
treatment/3-month follow-up (n = 12 and n = 23) on screening variables (all ps > .05).
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Primary Outcomes
Our primary outcome analyses (Hypotheses 1 & 2, n = 58) revealed that 30-day point
prevalence abstinence did not differ significantly between CBT (6.9%; 2 of 29) and CG (3.4%; 1
of 29) (χ2(1, N = 58) = .352, p = .553). However, the proportion of CBT participants (34.5%; 10
of 29) that reduced their smoking by 50% was significantly greater than that of CG (10.3%; 3 of
29) (χ2(1, N = 58) = 4.86, p = .028) (Figure 2).
Secondary Outcomes
With regard to abstinence and smoking reduction at 3 month follow-up (Hypothesis 3 &
4), results revealed no significant differences between groups on 30-day point prevalence
abstinence (10.3%; 3 of 29 in both groups, χ2(1, N = 58) = .000, p = 1.000). In addition, at 3month follow-up no significant differences emerged between groups on the proportion of
participants that reduced their smoking by 50% (CBT: 24.1%; 7 of 29 and CG: 17.2%; 5 of 29)
(χ2(1, N = 58) = .420, p = .747) (Figure 2).
Exploratory Outcomes
Results related to Hypothesis 5 show that CBT for college student smokers with elevated
depressive symptoms was feasible, demonstrated by the ability to recruit and retain participants,
treatment attendance, and treatment satisfaction. Out of 1380 potential participants screened, 58
(4.2%) were randomized to participate in the study, which exceeds the estimated and proposed
sample size of n = 50 (Figure 1). In addition, out of the participants that consented to be
contacted and met screening criteria for smoking, depressive symptoms, motivation, and no
MDD (n = 82), a moderate proportion (29.3%; 24 out of 82) refused to participate or could not
be reached by study personnel (Figure 1). With regard to retention, 79.3% (n = 46, 23 in each
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condition) of the 58 randomized participants completed at least one treatment session and end of
treatment data. For treatment attendance, 75.9% (n = 44) of the 58 randomized participants
completed at least 4 group sessions and numbers were similar across groups (CBT; n = 21, CG; n
= 23). Participants reported that the incentives had a “moderate” influence in whether or not they
continued to participate in the groups, and no significant group difference existed (p > .05). With
regard to treatment satisfaction among the CBT participants, 60.8% (n = 14) found the group
helpful for quitting smoking and 91.3% (n = 21) reported it was helpful for reducing smoking.
Furthermore, all CBT participants said they would recommend the group to a friend for quitting
or reducing smoking and 78.2% (n = 18) said they would come back to the group if they wanted
to change their smoking in the future. Among the CG participants, 86.9% (n = 22) found the
group helpful for increasing fruit and vegetable consumption. All CG participants said they
would recommend the group to a friend for increasing fruit and vegetable consumption and
86.9% (n = 20) said they would come back to the group if they wanted to increase their fruit and
vegetable consumption in the future. Of note, 78.1% (n = 25) of participants across two cohorts
of CBT and CG groups reported that they would prefer the group format to individual sessions.
Table 7 presents exploratory outcome data for participants with complete data (n = 46 at
end of treatment and n = 35 at 3-month follow-up). With regard to changes in number of
cigarettes smoked in the past 30 days from baseline to end of treatment and 3-month follow-up
(Hypothesis 6), repeated measures analysis of variance demonstrated a significant main effect for
time (F(1, 44) = 7.60, p = .008, ηp2 = .147) such that the average number of cigarettes smoked in
the past 30 days decreased from 235.22 (SD = 209.68) at baseline to 189.86 (SD = 227.32) at end
of treatment. In addition, the treatment group by time interaction approached significance (F(1,
44) = 2.95, p = .093, ηp2 = .063). At 3-month follow-up, repeated measures analysis of variance
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demonstrated a significant main effect for time (F(1, 33) = 14.40, p = .001, ηp2 = .304), but no
treatment group by time interaction (F(1, 33) = 2.41, p = .130, ηp2 = .068).
For motivation to quit and reduce smoking (Hypothesis 7), a significant main effect for
time emerged (Quit: F(1, 44) = 10.96, p = .002, ηp2 = .199; Reduce: F(1, 44) = 11.46, p = .002,
ηp2 = .207) but not a significant treatment by time interaction at end of treatment (Quit: F(1, 44)
= 2.23, p = .143, ηp2 = .048; Reduce: F(1, 44) = .02, p = .884, ηp2 = .000). No significant main
(F(1, 44) = 1.83, p = .183, ηp2 = .040) or interaction effect (F(1, 44) = 0.12, p = .737, ηp2 = .003)
emerged for confidence to quit smoking at end of treatment. However, a significant interaction
effect was found for confidence to reduce smoking (F(1, 44) = 4.35, p = .043, ηp2 = .090) at end
of treatment. CBT participants‟ average level of confidence to reduce smoking increased from
baseline to end of treatment to a significantly greater degree than CG participants (Figure 3). At
3-month follow-up, a significant main effect for time emerged for motivation to quit and reduce
smoking (Quit: F(1, 33) = 9.05, p = .005, ηp2 = .215; Reduce: F(1, 33) = 4.57, p = .040, ηp2 =
.122). Additionally, the treatment group by time interaction approached significance for
motivation to quit (F(1,33) = 3.18, p = .084, ηp2 = .088), but not for motivation to reduce (F(1,
33) = 0.73, p = .401, ηp2 = .022). For confidence to quit or reduce smoking at 3-month follow-up,
no significant main (Quit: F(1, 33) = 0.48, p = .493, ηp2 = .014; Reduce: F(1, 33) = 0.66, p =
.423, ηp2 = .020) or interaction effect (Quit: F(1, 33) = 0.31, p = .583, ηp2 = .009; Reduce: F(1,
33) = 1.35, p = .254, ηp2 = .039) emerged.
With regard to affect (NA and PA), mood (BDI-II), and cognition (NAR expectancies
and ERQ) outcomes (Hypothesis 8), no main (F(1, 44) = 0.55, p = .461, ηp2 = .012) or interaction
effect (F(1, 44) = 0.28, p = .598, ηp2 = .006) was found for the NA subscale of the PANAS at end
of treatment or 3-month follow-up (Main: F(1, 33) = 0.68, p = .417, ηp2 = .020; Interaction: F(1,
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33) = 0.75, p = .394, ηp2 = .022). In addition, no main (F(1, 44) = 0.00, p = 1.00, ηp2 = .000) or
interaction effect (F(1, 44) = 0.06, p = .815, ηp2 = .001) was found for the PA subscale of the
PANAS at end of treatment or 3-month follow-up (Main: F(1, 33) = 0.07, p = .795, ηp2 = .002;
Interaction: F(1, 33) = 2.59, p = .117, ηp2 = .073). For the BDI-II, a main effect for time
approached significance (F(1, 44) = 3.23, p = .079, ηp2 = .068), but no significant treatment by
time interaction emerged (F(1, 44) = 1.86, p = .180, ηp2 = .041) at end of treatment. At 3-month
follow-up, no main (F(1, 33) = 0.59, p = .448, ηp2 = .018) or interaction effect (F(1, 33) = 0.19, p
= .670, ηp2 = .006) was found for the BDI-II. For the Negative Affect Reduction (NAR) subscale
of the SCQ, we detected a significant main effect for time (F(1, 44) = 7.03, p = .011, ηp2 = .138),
but no interaction effect (F(1, 44) = 0.52, p = .474, ηp2 = .012) at end of treatment. In addition, at
3-month follow-up with the NAR subscale we found a significant main effect for time (F(1, 33)
= 12.14, p = .001, ηp2 = .269), but no interaction effect (F(1, 33) = 0.17, p = .684, ηp2 = .005). No
main (F(1, 44) = 0.50, p = .484, ηp2 = .011) or interaction effect (F(1, 44) = 0.09, p = .769, ηp2 =
.002) was found for the Reappraisal subscale of the ERQ at end of treatment or 3-month followup (Main: F(1, 33) = 1.95, p = .172, ηp2 = .056; Interaction: F(1, 33) = 0.41, p = .528, ηp2 = .012).
For the relationship between baseline depressive symptoms and treatment attendance,
linear regression analyses indicated that baseline depressive symptoms were not a significant
predictor of treatment attendance (B = .02, SE B = .03, β = 0.07, p = .620).
DISCUSSION
College student smoking rates are high and there is evidence that smoking initiation and
progression during the college years may influence adult smoking patterns. Furthermore, the
presence of depressive symptoms among college smokers is concerning, especially because it
may impede cessation efforts. Despite promising evidence for mood management interventions
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among smokers with clinically elevated depressive symptoms, no interventions of this kind have
been developed and tested for depressed college smokers. Thus, this study tested a multicomponent psychotherapeutic smoking reduction/cessation intervention designed for college
student smokers with elevated depressive symptoms.
The primary outcomes focused on smoking reduction and cessation. We found a
significantly greater proportion of CBT participants reduced smoking by at least 50% compared
to CG participants at end of treatment. This finding is remarkable given the small-scale nature of
our study. Smoking reduction is important given that many college students are not interested in
quitting immediately. For example, at baseline our sample had only a moderate interest in
quitting or reducing tobacco use. Researchers have found that spontaneous reduction is rare and
that smokers who reduce can maintain these reductions (Hughes & Carpenter, 2005). Therefore,
smoking reduction can be viewed as a significant outcome for the CBT group because it is
unlikely to happen on its own. In addition, there is some evidence that smoke exposure decreases
for those who reduce (Hughes & Carpenter, 2005) suggesting direct health implications for
reduction. Furthermore, given that smoking reduction increases the likelihood of future cessation
(Hughes & Carpenter, 2006), reductions made by CBT participants are an important step on the
path toward quitting. It is very possible that the smoking reductions that took place in the CBT
group may build self-efficacy for future quit attempts.
Indeed, we found a significant interaction effect such that CBT participants‟ confidence
to reduce smoking increased from baseline to end of treatment whereas it decreased for CG
participants. Confidence to change smoking behavior is similar to „quitting self-efficacy‟ which
is related to initiation of quit attempts (Baldwin et al., 2006), intention to continue smoking
(Landrum Sterling et al., 2007), and stage of change (Apodaca, Abrantes, Strong, Ramsey, &
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Brown, 2007; Hoving, Mudde, & de Vries, 2006). It is likely that making a behavior change
increases confidence and vice versa, and CBT participants may gain momentum toward
cessation if they continue to experience the combined effects of reduction and increases in
confidence. For instance, if confidence to reduce increases, then it may lead to confidence to quit
over time. Building self-efficacy is important for those making a quit attempt because low selfefficacy may predict relapse after cessation (Baer, Holt, & Lichtenstein, 1986; McIntyre,
Lichtenstein, & Mermelstein, 1983; Shiffman et al., 2000). Moreover, increasing confidence may
be especially vital for depressed smokers given that currently depressed smokers have been
found to have lower smoking cessation self-efficacy (Haukkala, Uutela, Vartiainen, McAlister,
& Knekt, 2000; John, Meyer, Rumpf, & Hapke, 2004b). Although the interaction effect was not
significant at 3-month follow-up, CBT participants‟ confidence to reduce smoking was
maintained (Table 7). In addition, the interaction effect for motivation to quit at 3-month followup approached significance, suggesting that CBT participants‟ motivation increased from
baseline to 3-month follow-up to a greater degree than CG participants. This promising finding
may be related to the synergistic effects that behavioral change and increased confidence can
have on motivation to quit. Increasing motivation to quit is an important step toward quitting.
Overall, few participants quit smoking across both groups. Although this finding differs
substantially from outcomes of mood management interventions among depressed adult
smokers, our study design differed from adult studies because we recruited occasional smokers
not ready to quit immediately. Qualitative reflections of CBT group leaders suggested that few
participants seemed interested in quitting, and participants‟ interest in reducing may have
resulted from a compromise related to their ambivalence toward quitting (e.g., “I want to quit,
but there are enough reasons to sustain my use. Reducing is appealing because it is a step toward
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quitting, yet I am still able to smoke”). In addition, CBT participants commented that they were
not ready to make a commitment to quitting now and talked about quitting as something they
“just had to be ready for.” Based on anecdotal evidence provided by CBT group leaders,
participants appeared aware of the current side effects of smoking, like difficulty breathing,
coughing up blood, and the smell of tobacco smoke on their hands, breath, and clothes. Despite
this awareness, they felt the immediate benefits of smoking (e.g., relieving stress, smoking being
enjoyable, and smoking being associated with drinking and socializing) outweighed the negative
physical effects. Participants reported awareness of the long-term risks of cigarette smoking
(e.g., cancer), but appeared to consider the short-term benefits as more appealing than potential
long-term consequences. Taken together, these observations based on clinical data from CBT
participants suggest that smoking reduction might be a more feasible short-term outcome than
cessation for smoking interventions among college smokers.
The secondary outcomes evaluated abstinence and reduction at 3-month follow-up.
Results showed that neither smoking abstinence nor smoking reduction rates differed
significantly between groups. Notably, abstinence and reduction rates increased from end of
treatment to 3-month follow-up in both groups (with the exception of a small decrease in 50%
reduction for the CBT group). These findings may indicate that progress in quitting and reducing
smoking remained fairly consistent for the CBT group whereas it increased for CG participants
over time. Indeed, number of cigarettes smoked in the past month did not increase, but remained
largely the same from end of treatment to 3-month follow-up in the CBT group. Patten et al.
(1998) found similar results such that abstinence rates in the CBT group were significantly
higher than standard behavioral counseling at end of treatment and 12-month follow-up, but not
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at 3-month follow-up. Six-month follow-up data for this study will be forthcoming and may
show a similar trend.
The exploratory results related to overall reduction in number of cigarettes smoked in the
past month revealed a trend toward greater reduction in the CBT group versus the CG group at
end of treatment. With more statistical power, this finding would likely be significant given the
medium effect size of the interaction term (ηp2 = .063, where .02, .06, and .14 represent small,
medium, and large effect sizes (Cohen, 1988)). This finding parallels the significant finding for
50% reduction at end of treatment and has similar implications for increased health, future
quitting, and enhanced confidence to quit. Although group differences in reduction in number of
cigarettes smoked in the past month were not significant at 3-month follow-up, it is important to
note that reductions were maintained by the CBT group from end of treatment to 3-month
follow-up. Maintenance of reduction by the CBT group suggests that the intervention might have
durable effects.
Findings related to recruitment, retention, treatment adherence, and satisfaction support
the feasibility of this intervention for depressed college student smokers. We recruited more
participants than our projected sample size of 50, and a substantial number (70.7%) of those
contacted to participate agreed. Likewise, we had low attrition and few missed sessions across
both groups, which is especially notable given that participants were not necessarily seeking any
type of treatment. It is important to mention that we were diligent about following up when
participants missed sessions and about scheduling make-up sessions. Participant incentives were
rated as only “moderately” important for participants‟ continued engagement in the study.
Consistent with this, CBT group leaders observed CBT participants‟ comments that they had
made a commitment to attending sessions and planned to honor that commitment, and that they
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enjoyed meeting with a group of college students to discuss smoking. These observations
suggested that group smoking interventions may be particularly useful for enhancing
participation and lowering attrition.
Given that this is a new treatment in a previously understudied population, our findings
for high treatment satisfaction in the CBT group are noteworthy. Over half (61%) of CBT
participants found the group helpful for quitting smoking and almost all (91%) found it helpful
for reducing smoking. Moreover, the likelihood that a similar intervention would be used in the
future is high given that all participants said they would recommend the group to a friend. Nearly
80% of CBT participants reported they would return to the group in the future if they wanted to
change their smoking. Thus, the intervention was useful for reducing smoking in a sample with
low motivation to quit, and it was also well received and viewed positively by a group of nontreatment seeking college smokers. Treatment satisfaction was similarly high in the nutrition
group. In conjunction with the lack of between group differences in retention and attendance,
these satisfaction data support the use of this nutrition-focused group as an adequate control
group.
With regard to negative affect and depressive symptoms, our findings showed trends in
the expected direction at end of treatment such that negative affect and depressed mood
decreased in CBT participants and remained largely the same in the CG group (Table 7).
Statistically significant differences between groups would likely emerge with a larger sample
size and might provide insight into the mechanism of action for the 50% reduction finding.
Interestingly, both affect (NA and PA) and mood worsened slightly across groups from end of
treatment to 3-month follow-up. It is difficult to know the source or stability of these changes,
but 6-month follow-up data might provide more information. For example, if affect and mood
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improve for both groups at 6-month follow-up it may mean that these variables are subject to
slight fluctuations in a college sample. Despite the worsening of affect and mood at 3-month
follow-up, cognitive reappraisal strategies increased slightly from end of treatment to 3-month
follow-up. Again, this finding warrants follow-up because we would expect affect and mood and
cognitive strategies to improve (or worsen) together over time.
Results related to the exploratory hypotheses also revealed significant main effects for
time such that overall number of cigarettes smoked per month and negative affect regulation
expectancies decreased, whereas motivation to quit and reduce increased from baseline to end of
treatment and 3-month follow-up across groups. These main effects for time indicate that there
might be some benefit to participating in a health-focused group. However, it is important to
point out that an increase in confidence and significant reduction (≥ 50%) occurred at end of
treatment with the extra attention paid to smoking behavior in the CBT group.
Lastly, we examined the relationship between baseline depressive symptoms and
treatment attendance because there is some evidence to suggest that smokers experiencing more
depressive symptomatology are more likely to attend CBT treatment sessions compared to
smokers with lower depressive symptoms (Patten et al., 2002). However, results revealed no
significant relationship between baseline BDI-II scores and attendance. It is possible that we did
not have enough variability in depression scores given that we selected for clinically elevated
depressive symptomatology.
There are a few limitations to note. First, this was a small-scale study intended to
evaluate the promise of this novel intervention before conducting a larger scale study. As such,
our sample size is small, which might represent a limitation. On the other hand, the small sample
places our significant results in context and suggests that some of the observed statistical trends
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would likely achieve significance with a larger sample size. Second, our primary outcomes were
examined at end of treatment and 3-month follow-up. Six-month follow-up data are being
collected and planned analyses will confirm whether reductions were maintained over a longer
length of time. Third, related to sample demographics, our study was conducted at a single site,
and the majority of the participants were white and early in their college careers. Future studies
should examine a more diverse group of participants and generalization of the present results
should be done with caution. In addition, future studies could investigate which components
(behavioral, mood management, or motivational) of the combined intervention are responsible
for smoking reduction and increases in confidence. Lastly, it is not possible to biochemically
confirm smoking cessation over a 30-day period. It should be noted that our results are based on
self-report and that we used saliva samples to help increase the accuracy of self-reporting.
Concluding Comments and Reflections
To our knowledge, our study is the first to evaluate a multi-component treatment among
college smokers with elevated depressive symptoms. Given this novelty, we encountered a few
surprises and challenges along the way. With regard to surprises, CBT group leaders remarked
how engaged participants were in group discussion. Some CBT participants commented that they
do not talk about smoking with their friends and that they liked having the opportunity to talk
with other college smokers about their experiences. Participants stated that they felt validated to
hear that other people experience similar side effects, like coughing upon waking and difficulty
breathing. Group leaders noted that participants had many shared experiences, like difficulty
quitting when all their friends smoke and perceptions of isolation related to being the “odd man
out” if everyone else at a party was smoking and they were not. In addition, group leaders
commented that CBT participants enjoyed discussing how they felt irritated and wanted to
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smoke more when strangers reacted negatively toward their smoking (e.g., plugging their nose as
they walk by or saying, “That stuff will kill you”). Overall, there appeared to be the sense that if
the participants were going to quit it would be on their own terms and in their own way. This
quality of individuation and independence should be noted when working with college student
smokers. Another surprise was that many participants did not seem to realize that they were in a
group of moderately depressed individuals. CBT group leaders commented that when
participants talked about mood regulation, they talked about stress, but not sadness or depression.
Although it is possible that being in a group with other students may have made it more difficult
for participants to talk openly about depressed mood; it is also possible that the link between
depression and smoking was less clear to participants than group leaders intended it to be. In the
future, it may be effective to talk about low mood directly and how it is associated with
ineffective coping styles, such as smoking and how smoking may perpetuate low mood. Talking
about how smoking as a coping strategy influences mood may be an avenue to tap into
participant values because many people do not want to feel sad or depressed. Thus, depression
may provide an opportunity to link smoking to values in terms of motivational enhancement.
However, care should be taken when addressing mood and coping more directly in a group
setting because people may feel sensitive about experiencing low mood. It might be helpful to
talk about low mood as something that everyone experiences and how it affects coping, and then
go from there. In other words, group leaders would not single people out, but would take care to
talk about it in a more general sense.
With regard to challenges encountered, there was some difficulty in combining skills
training (cognitive or behavioral) and motivational enhancement. For example, group leaders
commented that it was challenging to teach coping skills to a group of participants that were not
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motivated to use them. Over three cohorts of groups, CBT group leaders modified the treatment
manual by incorporating more motivation in the beginning sessions and more skills training in
the end. Most CBT smoking interventions have been designed for smokers engaged in a quit
attempt where CBT is used to help smokers cope with that quit attempt. It is possible that mood
management approaches are less appropriate for smokers not ready to quit immediately because
they are not faced with the total absence of an apparently helpful but ultimately harmful mood
regulating strategy (i.e., smoking). Therefore, it may be more effective for the CBT component
to come later in the change process when smokers are ready to make a quit attempt. Also related
to the discontinuity between skills training and motivation, most participants did not do assigned
homework aside from self-monitoring of smoking. To compensate for this, group leaders had
participants give examples of self-management of smoking, challenges of thought distortions,
etc. in session. Additionally, group dynamics affected the motivational enhancement component.
For example, in one cohort there was an outspoken “pro-smoking” group member, which seemed
to influence the group dynamic in a direction away from change. However, for the other two
cohorts, group leaders noted that more participants were at the upper end of the motivation scale
which seemed to promote change talk. It may be the case that group motivational enhancement is
more effective when the group overall leans in the motivated direction and that one strong
dissenter can impact group progress. Rolling with resistance is a core principle of motivational
interviewing and therapists should continue to work with dissenters in this manner. However, in
groups therapist control over resistance may be reduced because non-motivational interviewing
strategies may arise among group members (e.g., other members may not roll with resistance or
be accepting of others‟ point of view).
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There were also a few challenges related to logistic issues. For example, our initial plan
for monitoring therapist adherence was to use tapes from group sessions to rate adherence to the
manuals. However, because this was a pilot study, we found that the outline of group topics
needed to be modified by cohort to increase intervention effectiveness. In addition, tapes were
incomplete and so we substituted case notes for a less-detailed analysis of therapist adherence.
CBT group participants also reported that two hours was too long to sit in the group and that they
preferred one and a half hour groups. Lastly, group CBT leaders recommended that the six
sessions occur weekly instead of including a month break because of lost momentum over the
break and participant fatigue at the end of the semester when the final group session took place.
Despite the limitations and challenges encountered, this study shows promising evidence
for the utility of this multi-component treatment for smoking reduction among college smokers
with elevated depressive symptoms. CBT participants reported that the groups made them more
aware of their smoking and made their behavior less automatic, which helped them change their
use. Depressed college smokers are an understudied population and positive behavior change in
these smokers is significant given that they were not treatment seeking and were not motivated to
quit immediately. The large smoking reductions found in our CBT group also have high clinical
significance because reducing smoking may lower morbidity and lead to future smoking
cessation.

38
REFERENCES
Abrams, D. B., Niaura, R., Brown, R. A., Emmons, K., Goldstein, M. G., & Monti, P. M. (2003).
The tobacco dependence treatment handbook: A guide to best practices. New York:
Guilford Press.
Adewuya, A. O., Ola, B. A., & Afolabi, O. O. (2006). Validity of the patient health questionnaire
(PHQ-9) as a screening tool for depression amongst Nigerian university students. Journal
of Affective Disorders, 96(1-2), 89-93.
Anda, R. F., Williamson, D. F., Escobedo, L. G., Mast, E. E., Giovino, G. A., & Remington, P.
L. (1990). Depression and the dynamics of smoking: A national perspective. Journal of
the American Medical Association, 264(12), 1541-1545.
Apodaca, T. R., Abrantes, A. M., Strong, D. R., Ramsey, S. E., & Brown, R. A. (2007).
Readiness to change smoking behavior in adolescents with psychiatric disorders.
Addictive Behaviors, 32(6), 1119-1130.
Attkisson, C. C., & Zwick, R. (1982). The client satisfaction questionnaire: Psychometric
properties and correlations with service utilization and psychotherapy outcome.
Evaluation and Program Planning, 5(3), 233-237.
Baer, J. S., Holt, C. S., & Lichtenstein, E. (1986). Self-efficacy and smoking reexamined:
Construct validity and clinical utility. Journal of Consulting & Clinical Psychology,
54(6), 846-852.
Baldwin, A. S., Rothman, A. J., Hertel, A. W., Linde, J. A., Jeffery, R. W., Finch, E. A., et al.
(2006). Specifying the determinants of the initiation and maintenance of behavior change:
An examination of self-efficacy, satisfaction, and smoking cessation. Health Psychology,
25(5), 626-634.

39
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-Second Edition. San Antonio, TX: Psychological Corporation.
Biener, L., & Abrams, D. B. (1991). The Contemplation Ladder: Validation of a measure of
readiness to consider smoking cessation. Health Psychology, 10(5), 360-365.
Black, D. R., & Babrow, A. S. (1991). Identification of campaign recruitment strategies for a
stepped smoking cessation intervention for a college campus. Health Education
Quarterly, 18(2), 235-247.
Bono, C., Ried, L. D., Kimberlin, C., & Vogel, B. (2007). Missing data on the Center for
Epidemiologic Studies Depression Scale: A comparison of 4 imputation techniques.
Research in Social and Administrative Pharmacy, 3(1), 1-27.
Brandon, T. H., Copeland, A. L., & Saper, Z. L. (1995). Programmed therapeutic messages as a
smoking treatment adjunct: Reducing the impact of negative affect. Health Psychology,
14(1), 41-47.
Breslau, N., Fenn, N., & Peterson, E. L. (1993). Early smoking initiation and nicotine
dependence in a cohort of young adults. Drug and Alcohol Dependence, 33(2), 129-137.
Breslau, N., Kilbey, M., & Andreski, P. (1991). Nicotine dependence, major depression, and
anxiety in young adults. Archives of General Psychiatry, 48(12), 1069-1074.
Breslau, N., Kilbey, M. M., & Andreski, P. (1993). Nicotine dependence and major depression:
New evidence from a prospective investigation. Archives of General Psychiatry, 50(1),
31-35.
Breslau, N., Peterson, E. L., Schultz, L. R., Chilcoat, H. D., & Andreski, P. (1998). Major
depression and stages of smoking: A longitudinal investigation. Archives of General
Psychiatry, 55(2), 161-166.

40
Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Sales, S. D., Ramsey, S. E., et al.
(2001). Cognitive-behavioral treatment for depression in smoking cessation. Journal of
Consulting and Clinical Psychology, 69(3), 471-480.
Brown, R. A., Lewinsohn, P. M., Seeley, J. R., & Wagner, E. F. (1996). Cigarette smoking,
major depression, and other psychiatric disorders among adolescents. Journal of the
American Academy of Child and Adolescent Psychiatry, 35(12), 1602-1610.
Brown, R. A., Niaura, R., Lloyd-Richardson, E. E., Strong, D. R., Kahler, C. W., Abrantes, A.
M., et al. (2007). Bupropion and cognitive-behavioral treatment for depression in
smoking cessation. Nicotine & Tobacco Research, 9(7), 721-730.
Carmody, T. P. (1989). Affect regulation, nicotine addiction, and smoking cessation. Journal of
Psychoactive Drugs, 21(3), 331-342.
Carpenter, M. J., Hughes, J. R., Solomon, L. J., & Callas, P. W. (2004). Both smoking reduction
with nicotine replacement therapy and motivational advice increase future cessation
among smokers unmotivated to quit. Journal of Consulting and Clinical Psychology,
72(3), 371-381.
Carton, S., Jouvent, R., & Widlocher, D. (1994). Nicotine dependence and motives for smoking
in depression. Journal of Substance Abuse, 6(1), 67-76.
Center for Disease Control and Prevention. (1994). From data to action: CDC's public health
surveillance for women, infants, and children. Atlanta, GA: HHS, CDC, NCCDPHP.
Centers for Disease Control and Prevention. (1993). Smoking cessation during previous year
among adults--United States, 1990-1991. MMWR - Morbidity & Mortality Weekly
Report, 42, 504-507.

41
Centers for Disease Control and Prevention. (1997a). Cigarette smoking among adults--United
States, 1995. MMWR - Morbidity & Mortality Weekly Report, 46(51), 1217-1220.
Centers for Disease Control and Prevention. (1997b). Youth Risk Behavior Surveillance:
National College Health Risk Behavior Survey--United States, 1995. Morbidity &
Mortality Weekly Report. CDC Surveillance Summaries, 46(6), 1-56.
Chan, C. W., & Witherspoon, J. M. (1988). Health risk appraisal modifies cigarette smoking
behavior among college students. Journal of General Internal Medicine, 3(6), 555-559.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York:
Erlbaum.
Copeland, A. L., Brandon, T. H., & Quinn, E. P. (1995). The Smoking Consequences
Questionnaire-Adult: Measurement of smoking outcome expectancies of experienced
smokers. Psychological Assessment, 7(4), 484-494.
Covey, L. S., Hughes, D. C., Glassman, A. H., Blazer, D. G., & George, L. K. (1994). Eversmoking, quitting, and psychiatric disorders: Evidence from the Durham, North Carolina,
Epidemiologic Catchment Area. Tobacco Control, 3, 222-227.
Curry, S. J., McBride, C., Grothaus, L. C., Louie, D., & Wagner, E. H. (1995). A randomized
trial of self-help materials, personalized feedback, and telephone counseling with
nonvolunteer smokers. Journal of Consulting and Clinical Psychology, 63(6), 1005-1014.
DeBernardo, R. L., Aldinger, C. E., Dawood, O. R., Hanson, R. E., Lee, S. J., & Rinaldi, S. R.
(1999). An E-mail assessment of undergraduates' attitudes toward smoking. Journal of
American College Health, 48(2), 61-66.

42
Eisenberg, D., Gollust, S. E., Golberstein, E., & Hefner, J. L. (2007). Prevalence and correlates
of depression, anxiety, and suicidality among university students. American Journal of
Orthopsychiatry, 77(4), 534-542.
Everett, S. A., Husten, C. G., Kann, L., Warren, C. W., Sharp, D., & Crossett, L. (1999).
Smoking initiation and smoking patterns among US college students. Journal of
American College Health, 48(2), 55-60.
Ginsberg, J. P., Klesges, R. C., Johnson, K. C., Eck, L. H., Meyers, A. W., & Winders, S. A.
(1997). The relationship between a history of depression and adherence to a
multicomponent smoking-cessation program. Addictive Behaviors, 22(6), 783-787.
Glassman, A. H., Helzer, J. E., Covey, L. S., Cottler, L. B., Stetner, F., Tipp, J. E., et al. (1990).
Smoking, smoking cessation, and major depression. Journal of the American Medical
Association, 264(12), 1546-1549.
Glassman, A. H., Stetner, F., Walsh, B. T., Raizman, P. S., Fleiss, J. L., Cooper, T. B., et al.
(1988). Heavy smokers, smoking cessation, and clonidine: Results of a double-blind,
randomized trial. Journal of the American Medical Association, 259(19), 2863-2866.
Glynn, T. J., Boyd, G. M., & Gruman, J. C. (1990). Essential elements of self-help/minimal
intervention strategies for smoking cessation. Health Education Quarterly, 17(3), 329345.
Gross, J. J., & John, O. P. (2003). Individual differences in two emotion regulation processes:
Implications for affect, relationships, and well-being. Journal of Personality and Social
Psychology, 85(2), 348-362.

43
Haas, A. L., Munoz, R. F., Humfleet, G. L., Reus, V. I., & Hall, S. M. (2004). Influences of
mood, depression history, and treatment modality on outcomes in smoking cessation.
Journal of Consulting and Clinical Psychology, 72(4), 563-570.
Hall, S. M., Munoz, R. F., & Reus, V. I. (1994). Cognitive-behavioral intervention increases
abstinence rates for depressive-history smokers. Journal of Consulting and Clinical
Psychology, 62(1), 141-146.
Hall, S. M., Munoz, R. F., Reus, V. I., & Sees, K. L. (1993). Nicotine, negative affect, and
depression. Journal of Consulting and Clinical Psychology, 61(5), 761-767.
Hall, S. M., Munoz, R. F., Reus, V. I., Sees, K. L., Duncan, C., Humfleet, G. L., et al. (1996).
Mood management and nicotine gum in smoking treatment: A therapeutic contact and
placebo-controlled study. Journal of Consulting and Clinical Psychology, 64(5), 10031009.
Hall, S. M., Reus, V. I., Munoz, R. F., Sees, K. L., Humfleet, G., Hartz, D. T., et al. (1998).
Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.
Archives of General Psychiatry, 55(8), 683-690.
Halperin, A. C., & Rigotti, N. A. (2003). US public universities' compliance with recommended
tobacco-control policies. Journal of American College Health, 51(5), 181-188.
Harris, K. J., Golbeck, A. L., Cronk, N. J., Catley, D., Conway, K., & Williams, K. B. (In Press).
Timeline follow-back versus global self-reports of tobacco smoking: A comparison of
findings with non-daily smokers. Psychology of Addictive Behaviors.
Haukkala, A., Uutela, A., Vartiainen, E., McAlister, A., & Knekt, P. (2000). Depression and
smoking cessation: The role of motivation and self-efficacy. Addictive Behaviors, 25(2),
311-316.

44
Hayford, K. E., Patten, C. A., Rummans, T. A., Schroeder, D. R., Offord, K. P., Croghan, I. T., et
al. (1999). Efficacy of bupropion for smoking cessation in smokers with a former history
of major depression or alcoholism. British Journal of Psychiatry, 174, 173-178.
Hitsman, B., Borrelli, B., McChargue, D. E., Spring, B., & Niaura, R. (2003). History of
depression and smoking cessation outcome: A meta-analysis. Journal of Consulting and
Clinical Psychology, 71(4), 657-663.
Hoving, E. F., Mudde, A. N., & de Vries, H. (2006). Smoking and the O pattern: Predictors of
transitions through the stages of change. Health Education Research, 21(3), 305-314.
Hu, M. C., Davies, M., & Kandel, D. B. (2006). Epidemiology and correlates of daily smoking
and nicotine dependence among young adults in the United States. American Journal of
Public Health, 96(2), 299-308.
Hughes, J. R. (1988). Clonidine, depression, and smoking cessation. Journal of the American
Medical Association, 259(19), 2901-2902.
Hughes, J. R., & Carpenter, M. J. (2005). The feasibility of smoking reduction: An update.
Addiction, 100(8), 1074-1089.
Hughes, J. R., & Carpenter, M. J. (2006). Does smoking reduction increase future cessation and
decrease disease risk? A qualitative review. Nicotine & Tobacco Research, 8(6), 739749.
John, U., Meyer, C., Rumpf, H. J., & Hapke, U. (2004a). Depressive disorders are related to
nicotine dependence in the population but do not necessarily hamper smoking cessation.
Journal of Clinical Psychiatry, 65(2), 169-176.

45
John, U., Meyer, C., Rumpf, H. J., & Hapke, U. (2004b). Self-efficacy to refrain from smoking
predicted by major depression and nicotine dependence. Addictive Behaviors, 29(5), 857866.
Johnston, L., O‟Malley, P., Bachman, J., & Schulenberg, J. E. (2007). Monitoring the Future
national survey results on drug use, 1975–2006: Volume II, College students and adults
ages 19–45 (NIH Publication No. 07-6206). Bethesda, MD: National Institute on Drug
Abuse.
Kandel, D. B., & Davies, M. (1986). Adult sequelae of adolescent depressive symptoms.
Archives of General Psychiatry, 43(3), 255-262.
Kendler, K. S., Neale, M. C., MacLean, C. J., Heath, A. C., Eaves, L. J., & Kessler, R. C. (1993).
Smoking and major depression: A causal analysis. Archives of General Psychiatry, 50(1),
36-43.
Kinnunen, T., Doherty, K., Militello, F. S., & Garvey, A. J. (1996). Depression and smoking
cessation: Characteristics of depressed smokers and effects of nicotine replacement.
Journal of Consulting and Clinical Psychology, 64(4), 791-798.
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression
severity measure. Journal of General Internal Medicine, 16(9), 606-613.
Landrum Sterling, K., Diamond, P. M., Dolan Mullen, P., Pallonen, U., Ford, K. H., &
McAlister, A. L. (2007). Smoking-related self-efficacy, beliefs, and intention: Assessing
factorial validity and structural relationships in 9th-12th grade current smokers. Addictive
Behaviors, 32(9), 1863-1876.
Lee Ridner, S., Staten, R. R., & Danner, F. W. (2005). Smoking and depressive symptoms in a
college population. The Journal of School Nursing, 21(4), 229-235.

46
Lenz, B. K. (2004). Tobacco, depression, and lifestyle choices in the pivotal early college years.
Journal of American College Health, 52(5), 213-219.
Lerman, C., Audrain, J., Orleans, C. T., Boyd, R., Gold, K., Main, D., et al. (1996). Investigation
of mechanisms linking depressed mood to nicotine dependence. Addictive Behaviors,
21(1), 9-19.
Lerman, C., Caporaso, N., Main, D., Audrain, J., Boyd, N. R., Bowman, E. D., et al. (1998).
Depression and self-medication with nicotine: The modifying influence of the dopamine
D4 receptor gene. Health Psychology, 17(1), 56-62.
Mayhew, K. P., Flay, B. R., & Mott, J. A. (2000). Stages in the development of adolescent
smoking. Drug and Alcohol Dependence, 59 Suppl 1, S61-81.
McChargue, D. E., Spring, B., Cook, J. W., & Neumann, C. A. (2004). Reinforcement
expectations explain the relationship between depressive history and smoking status in
college students. Addictive Behaviors, 29(5), 991-994.
McIntyre, K. O., Lichtenstein, E., & Mermelstein, R. J. (1983). Self-efficacy and relapse in
smoking cessation: A replication and extension. Journal of Consulting and Clinical
Psychology, 51(4), 632-633.
Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change
addictive behavior. New York: Guilford Press.
Miller, W. R., & Rollnick, S. (2002). Motivational Interviewing: Preparing people for change.
(2nd ed.). New York: Guilford Press.
Murphy-Hoefer, R., Griffith, R., Pederson, L. L., Crossett, L., Iyer, S. R., & Hiller, M. D. (2005).
A review of interventions to reduce tobacco use in colleges and universities. American
Journal of Preventive Medicine, 28(2), 188-200.

47
Murphy, J. M., Horton, N. J., Monson, R. R., Laird, N. M., Sobol, A. M., & Leighton, A. H.
(2003). Cigarette smoking in relation to depression: Historical trends from the Stirling
County Study. American Journal of Psychiatry, 160(9), 1663-1669.
Murray, D. M., & Perry, C. L. (1987). The measurement of substance use among adolescents:
When is the 'bogus pipeline' method needed? Addictive Behaviors, 12(3), 225-233.
Niaura, R., Britt, D. M., Borrelli, B., Shadel, W. G., Abrams, D. B., & Goldstein, M. G. (1999).
History and symptoms of depression among smokers during a self-initiated quit attempt.
Nicotine & Tobacco Research, 1(3), 251-257.
Niaura, R., Britt, D. M., Shadel, W. G., Goldstein, M., Abrams, D., & Brown, R. (2001).
Symptoms of depression and survival experience among three samples of smokers trying
to quit. Psychology of Addictive Behaviors, 15(1), 13-17.
Okuyemi, K. S., Harris, K. J., Scheibmeir, M., Choi, W. S., Powell, J., & Ahluwalia, J. S. (2002).
Light smokers: Issues and recommendations. Nicotine & Tobacco Research, 4 Suppl 2,
S103-112.
Patten, C. A., Drews, A. A., Myers, M. G., Martin, J. E., & Wolter, T. D. (2002). Effect of
depressive symptoms on smoking abstinence and treatment adherence among smokers
with a history of alcohol dependence. Psychology of Addictive Behaviors, 16(2), 135-142.
Patten, C. A., Martin, J. E., Myers, M. G., Calfas, K. J., & Williams, C. D. (1998). Effectiveness
of cognitive-behavioral therapy for smokers with histories of alcohol dependence and
depression. Journal of Studies on Alcohol, 59(3), 327-335.
Patterson, F., Lerman, C., Kaufmann, V. G., Neuner, G. A., & Audrain-McGovern, J. (2004).
Cigarette smoking practices among American college students: Review and future
directions. Journal of American College Health, 52(5), 203-210.

48
Patton, G. C., Carlin, J. B., Coffey, C., Wolfe, R., Hibbert, M., & Bowes, G. (1998). Depression,
anxiety, and smoking initiation: A prospective study over 3 years. American Journal of
Public Health, 88(10), 1518-1522.
Patton, G. C., Hibbert, M., Rosier, M. J., Carlin, J. B., Caust, J., & Bowes, G. (1996). Is smoking
associated with depression and anxiety in teenagers? American Journal of Public Health,
86(2), 225-230.
Pinto-Meza, A., Serrano-Blanco, A., Penarrubia, M. T., Blanco, E., & Haro, J. M. (2005).
Assessing depression in primary care with the PHQ-9: Can it be carried out over the
telephone? Journal of General Internal Medicine, 20(8), 738-742.
Pomerleau, O. F., & Pomerleau, C. S. (1984). Neuroregulators and the reinforcement of
smoking: Towards a biobehavioral explanation. Neuroscience & Biobehavioral Review,
8(4), 503-513.
Psujek, J. K., Martz, D. M., Curtin, L., Michael, K. D., & Aeschleman, S. R. (2004). Gender
differences in the association among nicotine dependence, body image, depression, and
anxiety within a college population. Addictive Behaviors, 29(2), 375-380.
Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the
general population. Applied Psychological Measurement, 1(3), 385-401.
Ramsay, J., & Hoffmann, A. (2004). Smoking cessation and relapse prevention among
undergraduate students: A pilot demonstration project. Journal of American College
Health, 53(1), 11-18.
Schleicher, H. E., Harris, K. J., Catley, D., Harrar, S. W., & Golbeck, A. (2008). Examination of
a brief Smoking Consequences Questionnaire for college students. Nicotine & Tobacco
Research, 10(9), 1503-1509.

49
Schleicher, H. E., Harris, K. J., Catley, D., & Nazir, N. (In Press). The role of depression and
negative affect regulation expectancies in tobacco smoking among college students.
Journal of American College Health.
Shiffman, S., Balabanis, M. H., Paty, J. A., Engberg, J., Gwaltney, C. J., Liu, K. S., et al. (2000).
Dynamic effects of self-efficacy on smoking lapse and relapse. Health Psychology, 19(4),
315-323.
Sobell, L. C., & Sobell, M. B. (1996). Timeline FollowBack: Users Guide. Toronto, Ontario:
Addiction Research Foundation.
Steuber, T. L., & Danner, F. (2006). Adolescent smoking and depression: Which comes first?
Addictive Behaviors, 31(1), 133-136.
Tong, E. K., Ong, M. K., Vittinghoff, E., & Perez-Stable, E. J. (2006). Nondaily smokers should
be asked and advised to quit. American Journal of Preventive Medicine, 30(1), 23-30.
Vickers, K. S., Patten, C. A., Lane, K., Clark, M. M., Croghan, I. T., Schroeder, D. R., et al.
(2003). Depressed versus nondepressed young adult tobacco users: Differences in coping
style, weight concerns and exercise level. Health Psychology, 22(5), 498-503.
Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures
of positive and negative affect: The PANAS scales. Journal of Personality and Social
Psychology, 54(6), 1063-1070.
Wechsler, H., Rigotti, N. A., Gledhill-Hoyt, J., & Lee, H. (1998). Increased levels of cigarette
use among college students: A cause for national concern. Journal of the American
Medical Association, 280(19), 1673-1678.

50
Wetter, D. W., Kenford, S. L., Welsch, S. K., Smith, S. S., Fouladi, R. T., Fiore, M. C., et al.
(2004). Prevalence and predictors of transitions in smoking behavior among college
students. Health Psychology, 23(2), 168-177.
Windle, M., & Windle, R. C. (2001). Depressive symptoms and cigarette smoking among middle
adolescents: Prospective associations and intrapersonal and interpersonal influences.
Journal of Consulting and Clinical Psychology, 69(2), 215-226.
Wu, L. T., & Anthony, J. C. (1999). Tobacco smoking and depressed mood in late childhood and
early adolescence. American Journal of Public Health, 89(12), 1837-1840.
Zelman, D. C., Brandon, T. H., Jorenby, D. E., & Baker, T. B. (1992). Measures of affect and
nicotine dependence predict differential response to smoking cessation treatments.
Journal of Consulting and Clinical Psychology, 60(6), 943-952.

51
Table 1
Eligibility
Inclusion criteria

Exclusion criteria

 Age 18 years or older

 No current Major Depressive Disorder

 Smoked on 6 or more days out of the past
30 days
 CES-D Sum ≥ 16
 Contemplation Ladder score ≥ 3
 Enrolled with undergraduate standing at
The University of Montana
 Willing to participate in all study
components
 Provided informed consent

(MDD)
 No current suicidal intent or plan
 No participation in another structured
cessation program in the past 30 days
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Table 2
Study Overview and Incentives

Session

Week

Activity

Date range*

Incentive type

Screening
Session 1
(Baseline)
Session 2

-1

September

2 credits

October

4 credits

1

Screen, Randomize
CBT or CG Sessions
Baseline Measures
CBT or CG Sessions

October

Session 3

2

CBT or CG Sessions

October

2 credits, $5
$5, Non-monetary
incentives

Session 4

3

CBT or CG Sessions

October

$5, Non-monetary
incentives

4

CBT or CG Sessions

October

$5, Non-monetary
incentives

Session 6
(End of treatment)

8

CBT or CG Sessions
End of Treatment Measures

November

$20

3-month follow-up

12

3-month Follow-up
Measures

February

$10

Session 5

0

Note. *Date range from first cohort.
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Table 3
Topics Covered in Group Sessions for Treatment (CBT) and Control (CG) Conditions
Session

CBT

CG

Session 1

Introduce social learning approach,
assess motivation, and explain selfmonitoring of smoking and triggers.

Assess motivation, discuss 5 a day,
discuss health benefits, sample
fruit/vegetable (f/v), plan and set goals.

Session 2

Introduce behavioral chain, assess
motivation, introduce self-management
approach, and introduce thought
distortions.

Assess motivation, sample f/v, discuss
portion size, discuss colorful f/v, plan
and set goals.

Session 3

Assess motivation, review selfmanagement approach, review
behavioral chain, and introduce
disputing thought distortions.

Assess motivation, sample f/v, discuss
organic produce, discuss how to clean
f/v, discuss fresh, canned, frozen, and
dried f/v, discuss where to buy f/v, plan
and set goals.

Session 4

Assess motivation, review selfmanagement approach, review methods
for disputing thought distortions, and
set and plan for quit date.

Assess motivation, discuss label
reading, field trip to local grocery store,
plan and set goals.

Session 5

Assess motivation, review selfmanagement approach, review
disputing thought distortions, and
introduce relapse prevention.

Assess motivation, discuss eating f/v on
campus, sample f/v, discuss easy
recipes, plan and set goals.

Session 6

Review progress, assess motivation,
review self-management and disputing
thought distortions, and plan for the
future

Review progress, assess motivation,
review, discuss establishing a routine,
and plan for the future

Note. The session in which topics were covered varied slightly by cohort.
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Table 4
Percent of Sessions Topics were Covered
Intervention Topics
Cohort, Intervention Group

CBT

Behavioral Motivation
Counseling

F/V
Education

Cohort 1, CBT

91.7

100

58.6

0

Cohort 2, CBT

75.0

100

75.0

0

Cohort 3, CBT

66.7

91.7

91.7

0

Cohort 1, CG

0

0

41.7

100

Cohort 2, CG

0

0

66.7

91.7

Cohort 3, CG

0

0

91.7

100
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Table 5
Screening Sample Characteristics
Eligible
a

Characteristics of Sample n (%)
Age: M (SD)
30-day Smoking: M (SD)
CES-D Score: M (SD)
Contemplation Ladder: M (SD)
Gender: n (%)
Female
Male
Year in School: n (%)
Freshman
Sophomore
Junior
Senior
Other

Total
1380
19.68 (3.47)
3.88 (8.90)
13.81 (9.21)
5.57 (3.47)

Yes
58 (4.2)
21.00 (4.45)
23.72 (7.79)
25.13 (8.20)
6.66 (2.11)

850 (61.6)
530 (38.4)

30 (51.7)
28 (48.3)

982 (71.2)
246 (17.8)
106 (7.7)
29 (2.1)
17 (12.0)

41 (70.7)
13 (22.4)
2 (3.4)
1 (1.7)
1 (1.7)

No
p-value
1322 (95.8)
19.62 (3.41) .023*
3.01 (7.88) <.001*
13.31 (8.93) <.001*
5.32 (3.67) <.001*
.114
820 (62.0)
502 (38.0)
.683
941 (71.2)
233 (17.6)
104 (7.9)
28 (2.1)
16 (1.2)

Note. * p<.05, Eligible = met inclusion/exclusion criteria, 30-day Smoking = number of days
smoked in the past 30 days, CES-D = Center for Epidemiological Studies-Depression Scale. a
Total sample (n=1380) includes participants with missing data on 30-day Smoking (n=1), CES-D
Score (n=16), and Contemplation Ladder (n=75).
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Table 6
Demographic Characteristics and Baseline Measure Scores by Intervention Group
Intervention group
Total a
(n = 53)

CBT
(n = 26)

CG
(n = 27)

p-value

Demographic Characteristics, n (%)
21.19 (4.60)
21.78 (4.85) .347
Age, M (SD)
20.58 (4.34)
.217
Gender
27 (50.9)
16 (59.3)
Female
11 (42.3)
26 (49.1)
11 (40.7)
Male
15 (57.7)
.361
Year in School
36 (67.9)
16 (59.3)
Freshman
20 (76.9)
13 (24.5)
9 (33.3)
Sophomore
4 (15.4)
2 (3.8)
1 (3.7)
Junior
1 (3.8)
1 (1.9)
1 (3.7)
Senior
0
1 (1.9)
0
Other
1 (3.8)
.703
Ethnicity
44 (84.6)
21 (80.8)
White
23 (88.5)
8 (15.4)
5 (19.2)
Other
3 (11.5)
Psychotherapy Experience, Yes
4 (7.5)
1 (3.7) .280
Current
3 (11.5)
32 (60.4)
16 (59.3) .865
Past
16 (61.5)
10 (18.9)
4 (14.8) .501 b
Psychotropic Medication, Yes
6 (23.1)
21 (39.6)
11 (40.7) .865
Other 30-day tobacco use, Yes
10 (38.5)
Baseline Measures, M (SD)
24.77 (7.11)
24.07 (7.71) .471
30-day smoking
25.50 (6.50)
16.19 (5.30)
15.00 (4.32) .096
PANAS Negative Affect score
17.42 (5.99)
6.00 (2.70)
6.19 (2.65) .616
Motivation to Quit
5.81 (2.80)
7.00 (2.87)
6.74 (3.06) .508
Motivation to Reduce
7.27 (2.69)
6.89 (2.66)
6.81 (2.80) .843
Confidence to Quit
6.96 (2.55)
7.92 (2.34)
7.93 (2.39) .997
Confidence to Reduce
7.92 (2.33)
25.43 (7.74)
26.52 (8.27) .303
PANAS Positive Affect score
24.31 (7.17)
13.71 (8.82)
12.00 (7.50) .151
BDI-II score
15.49 (9.84)
7.69 (1.95)
7.62 (1.99) .798
SCQ Negative Affect Reduction score
7.76 (1.94)
4.37 (1.16)
4.36 (1.15) .965
ERQ Reappraisal score
4.38 (1.19)
a
Note. Total sample (n = 53) includes one participant who refused to provide ethnicity data and
excludes five participants (CBT n = 3, CG n = 2) who did not complete baseline data. b Fisher‟s
exact test used. 30-day Smoking = Number of days smoked in the past 30 days; PANAS =
Positive and Negative Affect Schedule; BDI-II Score Beck Depression Inventory-II; SCQ =
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Smoking Consequences Questionnaire; ERQ = Emotion Regulation Questionnaire.
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Table 7
Means and Standard Deviations for Exploratory Outcomes by Intervention Group

Exploratory Outcome Measures

Smoking
Cigs 30-days
Baseline
EOT
3-month
Motivation
Motivation to Quit
Baseline
EOT
3-month
Motivation to Reduce
Baseline
EOT
3-month
Confidence to Quit
Baseline
EOT
3-month
Confidence to Reduce
Baseline
EOT
3-month
Affect, Mood and Cognition
PANAS-Negative Affect
Baseline
EOT
3-month
PANAS-Positive Affect
Baseline
EOT
3-month
BDI-II
Baseline
EOT
3-month
SCQ-Negative Affect Reduction
Baseline
EOT

Total
(n = 46, EOT)
(n = 35, 3-month)

Intervention Group
CBT
CG
(n = 23, EOT)
(n = 23, EOT)
(n = 20, 3-month) (n = 15, 3-month)

235.22 (209.68)
189.87 (227.32) b
178.97 (202.40) b

239.78 (170.01)
166.17 (155.10)
166.70 (166.54)

230.65 (246.95)
213.57 (283.68)
195.33 (247.67)

5.74 (2.70)
6.85 (2.49) b
7.37 (2.26) b

5.83 (2.96)
7.43 (2.37)
8.05 (1.50)

5.65 (2.48)
6.26 (2.53)
6.47 (2.80)

6.65 (2.89)
8.15 (2.78) b
8.20 (2.68) b

7.13 (2.80)
8.70 (2.31)
8.60 (2.56)

6.17 (2.96)
7.61 (3.15)
7.67 (2.82)

6.87 (2.71)
7.39 (2.83)
7.40 (2.84)

6.91 (2.64)
7.30 (2.69)
7.45 (2.72)

6.83 (2.84)
7.48 (3.03)
7.33 (3.09)

7.87 (2.45)
8.33 (2.85)
8.46 (1.92)

7.78 (2.43)
9.09 (2.02) c
8.60 (1.64)

7.96 (2.51)
7.57 (3.36) c
8.27 (2.28)

16.74 (5.43)
15.98 (6.03)
17.60 (6.80)

18.17 (5.95)
16.87 (7.12)
17.65 (7.43)

15.30 (4.53)
15.09 (4.68)
17.53 (6.12)

25.26 (7.32)
25.26 (7.20)
24.17 (7.45)

24.83 (7.38)
24.61 (7.81)
23.60 (8.29)

25.70 (7.39)
25.91 (6.64)
24.93 (6.36)

13.95 (9.12)
12.05 (8.21)
12.43 (10.38)

15.95 (10.37)
12.61 (8.74)
13.05 (11.42)

11.96 (7.38)
11.50 (7.80)
11.60 (9.14)

7.67 (2.07)
7.01 (2.60) b

7.84 (2.03)
7.36 (2.40)

7.50 (2.13)
6.66 (2.79)

a
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3-month
6.91 (2.39) b
6.91 (2.35)
6.92 (2.53)
ERQ-Reappraisal
Baseline
4.39 (1.22)
4.35 (1.25)
4.43 (1.21)
EOT
4.28 (1.28)
4.19 (1.23)
4.36 (1.35)
3-month
4.62 (0.98)
4.68 (0.64)
4.54 (1.33)
a
Note. = Total sample at end of treatment (n = 46) excludes 12 participants who did not
complete any treatment sessions (n = 3), did not provide end of treatment data (n = 4), or did not
do both (n = 5). Total sample at 3-month follow-up (n = 35) excludes 23 participants who did not
complete any treatment sessions (n = 3), did not provide 3-month follow-up data (n = 15), or did
not do both (n = 5). b = Significant main effect for time (p < .05); c = Significant treatment by
time interaction effect (p < .05); EOT = End of Treatment; 3-month = 3-month Follow-up; Cigs
30-days = Number of cigarettes smoked in the past 30 days; PANAS = Positive and Negative
Affect Schedule; BDI-II = Beck Depression Inventory-II; SCQ = Smoking Consequences
Questionnaire; ERQ = Emotion Regulation Questionnaire.
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Assessed for eligibility at screening
(n = 1380)

Excluded (n = 1322), Reasons:*
Did not consent to be contacted (n = 253)
Smoking criterion not met (n = 1163)
Depressive symptoms criterion not met (n = 892)
Motivation criterion not met (n = 1145)
Current Major Depression (n = 4)
Refused to participate (n = 6)
Could not be reached (n = 18)
*Reasons are not mutually exclusive

Randomized (n = 58)

Allocated to Smoking Group (CBT) (n = 29)
Completed Baseline questionnaires: n = 26
Completed 0 Sessions: n = 4a
Completed 1 Session: n = 1
Completed 2 Sessions: n = 2
Completed 3 Sessions: n = 1
Completed 4 Sessions: n = 0
Completed 5 Sessions: n = 2
Completed 6 Sessions: n = 19
a
Reasons: Refused to participate, could not be
reached, or had time constraints

Withdrew consent (n = 0)
Lost to end of treatment (could not be
reached) (n = 5)
Lost to 3-month follow-up (could not be
reached) (n = 8)

Analyzed for primary outcomes using intent
to treat analyses (n = 29)
Analyzed for secondary & exploratory
outcome analyses (n = 23 at end of treatment
and n = 20 at 3-month follow-up)

Allocated to Nutrition Group (CG) (n = 29)
Completed Baseline questionnaires: n = 27
Completed 0 Sessions: n = 4b
Completed 1 Session: n = 1
Completed 2 Sessions: n = 1
Completed 3 Sessions: n = 0
Completed 4 Sessions: n = 2
Completed 5 Sessions: n = 1
Completed 6 Sessions: n = 20
b
Reasons: Refused to participate or had time
constraints

Withdrew consent (n = 2)
Lost to end of treatment (could not be reached)
(n = 2)
Lost to 3-month follow-up (could not be
reached) (n = 10)

Analyzed for primary outcomes using intent to
treat analyses (n = 29)
Analyzed for secondary & exploratory outcome
analyses (n = 23 at end of treatment and n = 15 at
3-month follow-up)

61

50

50% Reduction

40
30
CBT
CG

20
10
0
EOT

3-month
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Confidence to Reduce

10

CBT
CG

5

0
Baseline

EOT

